{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T14:40:11Z","timestamp":1786372811288,"version":"build-2736575974"},"reference-count":15,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJASN"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.2215\/cjn.12021017","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T20:35:16Z","timestamp":1512506116000},"page":"6-8","source":"Crossref","is-referenced-by-count":9,"title":["Lowering Expectations with Niacin Treatment for CKD-MBD"],"prefix":"10.2215","volume":"13","author":[{"given":"Tilman B.","family":"Dr\u00fceke","sequence":"first","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U-1018, Team 5, Centre de Recherche en Epid\u00e9miologie et Sant\u00e9 des Populations, Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Paris-Sud University and Paris Saclay University, Villejuif, France; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A.","family":"Massy","sequence":"additional","affiliation":[{"name":"Institut National de la Sant\u00e9 et de la Recherche M\u00e9dicale U-1018, Team 5, Centre de Recherche en Epid\u00e9miologie et Sant\u00e9 des Populations, Versailles Saint-Quentin-en-Yvelines University (Paris-Ile-de-France-Ouest University), Paris-Sud University and Paris Saclay University, Villejuif, France; and"},{"name":"Division of Nephrology, Ambroise Par\u00e9 Hospital, Assistance Publique-H\u00f4pitaux de Paris, Boulogne Billancourt\/Paris, France"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2017,12,5]]},"reference":[{"key":"B1-20230813","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/MNH.0000000000000236","article-title":"Nicotinamide and phosphate homeostasis in chronic kidney disease.","volume":"25","author":"Ginsberg","year":"2016","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"B2-20230813","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s40268-013-0024-6","article-title":"Use of nicotinamide to treat hyperphosphatemia in dialysis patients.","volume":"13","author":"Lenglet","year":"2013","journal-title":"Drugs R D"},{"key":"B3-20230813","doi-asserted-by":"crossref","first-page":"20B","DOI":"10.1016\/j.amjcard.2008.02.029","article-title":"Mechanism of action of niacin.","volume":"101","author":"Kamanna","year":"2008","journal-title":"Am J Cardiol"},{"issue":"Suppl 1","key":"B4-20230813","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1038\/sj.bjp.0707528","article-title":"Nicotinic acid: An old drug with a promising future.","volume":"153","author":"Bodor","year":"2008","journal-title":"Br J Pharmacol"},{"key":"B5-20230813","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1681\/ASN.2016080855","article-title":"Effect of tenapanor on serum phosphate in patients receiving hemodialysis.","volume":"28","author":"Block","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"B6-20230813","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2215\/CJN.05440517","article-title":"The effect of extended release niacin on markers of mineral metabolism in chronic kidney disease.","volume":"13","author":"Malhotra","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"B7-20230813","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"B8-20230813","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ndt\/gfx249","article-title":"Efficacy and safety of nicotinamide in haemodialysis patients: The NICOREN study.","volume":"32","author":"Lenglet","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"B9-20230813","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1016\/j.hoc.2012.02.012","article-title":"Poly(Adenosine diphosphate-ribose) polymerase inhibitors in cancer treatment.","volume":"26","author":"Park","year":"2012","journal-title":"Hematol Oncol Clin North Am"},{"key":"B10-20230813","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease-Mineral and Bone Disorder (CKD-MBD) guideline update: What\u2019s changed and why it matters.","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"B11-20230813","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s40620-016-0266-9","article-title":"Phosphate binders in chronic kidney disease: A systematic review of recent data.","volume":"29","author":"Floege","year":"2016","journal-title":"J Nephrol"},{"key":"B12-20230813","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1007\/s40265-017-0758-5","article-title":"A review of phosphate binders in chronic kidney disease: Incremental progress or just higher costs?","volume":"77","author":"Peter","year":"2017","journal-title":"Drugs"},{"key":"B13-20230813","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1681\/ASN.2012030223","article-title":"Effects of phosphate binders in moderate CKD.","volume":"23","author":"Block","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B14-20230813","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1681\/ASN.2012060569","article-title":"Phosphate binders in CKD: Bad news or good news?","volume":"23","author":"Dr\u00fceke","year":"2012","journal-title":"J Am Soc Nephrol"},{"key":"B15-20230813","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1681\/ASN.2015020117","article-title":"Rationale and approaches to phosphate and fibroblast growth factor 23 reduction in CKD.","volume":"26","author":"Isakova","year":"2015","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical Journal of the American Society of Nephrology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/01277230-201801000-00004","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T13:37:26Z","timestamp":1786369046000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/01277230-201801000-00004"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12,5]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018]]}},"URL":"https:\/\/doi.org\/10.2215\/cjn.12021017","relation":{},"ISSN":["1555-9041","1555-905X"],"issn-type":[{"value":"1555-9041","type":"print"},{"value":"1555-905X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,12,5]]}}}